Clinical Trials Browser

Hypoxia, Head and Neck Neoplasms

NCT04995185 2024-05-16

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

Phase NA Completed

9 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Hypoxia, Nasopharyngeal Neoplasms

NCT01827709 2023-04-03

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

Phase NA Terminated

11 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia, Head and Neck Neoplasms

NCT02661152 2021-04-13

DAHANCA30

Phase 3 Unknown

1,252 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia

NCT03547388 2020-05-05

GKH-TMM

Phase 1 Completed

10 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hyperthermia, Hypoxia, Head and Neck Neoplasms, Recurrence

NCT02976883 2019-01-11

OXYPET

Phase 2 Completed

8 enrolled

Head & NeckThoracic

Hypoxia, Head and Neck Neoplasms, Lung Neoplasms

NCT03098160 2017-10-30

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Phase 1 Unknown

69 enrolled

DermatologicGastrointestinalGenitourinaryHead & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia, Melanoma, Pancreatic Neoplasms, Prostatic Neoplasms

NCT01347281 2017-01-30

PET With [18F]HX4 in Head and Neck Cancer

Phase NA Completed

23 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

NCT02414048 2016-06-17

Hypoxia Analysis in Head and/or Neck Cancer

Phase 2 Unknown

10 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

NCT01212354 2016-02-09

Escalox

Phase 3 Unknown

270 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

NCT01213030 2012-09-25

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Phase 1/2 Completed

12 enrolled

GastrointestinalHead & NeckThoracic

Hypoxia, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms

NCT00884520 2010-03-16

VM4-037

Phase EARLY_PHASE1 Completed

16 enrolled

GastrointestinalGenitourinaryHead & NeckThoracic

Hypoxia, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms

Clinical Trials

FARHEAD

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

DAHANCA30

GKH-TMM

OXYPET

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

PET With [18F]HX4 in Head and Neck Cancer

Hypoxia Analysis in Head and/or Neck Cancer

Escalox

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

VM4-037